Prosthesis Dependant Left Ventricular Mass Regression After Aortic Valve Replacement. A Prospective Randomized Trial.

OBJECTIVES: This study assesses the hemodynamic performance of various aortic valve substitutes, the subsequent regression of left ventricular hypertrophy and the clinical outcomes after aortic valve replacement, in different age groups

METHODS: A total of 120 patients with isolated aortic valve stenosis were included in this prospective randomized trial. In group I (age 75 years), patients received a stentless bioprosthesis (CE Prima Plus n=20) or a stented bioprosthesis (CE Perimount n=20).

RESULTS: At 12 months, in group I, pulmonary autografts had significantly lower mean gradients when compared to mechanical valves ( 2.6 vs 10.9 mmHg, p=0.0005). Left ventricular mass regression however, was comparable in both groups (114±27.2 vs 110±30.2 g/m²). In group II, mean gradients were lower for stentless bioprostheses compared to mechanical valves (7.0 vs 8.9 mmHg, p=0.81), however it did not reach statistical significance. The rate of left ventricular mass regression was comparable(109±29.3 vs 111±27.6 g/m²). In group III, mean gradients did not differ significantly (7.8 vs 6.5 mmHg, p=0.06).Regression of left ventricular mass was comparable in both groups (104±28.5 vs 106±32.5 g/m²).

CONCLUSIONS: The rate and completeness of left ventricular mass regression was uniform for all prostheses and was not influenced by the differences in transvalvular gradients.

Author(s): Mirko Doss, Heinz Deschka, Petar Risteski, Gerhard Wimmer Greinecker, Anton Moritz

Decalcification of the Mitral Annulus: Surgical Experience in 81 Patients.

OBJECTIVE: Mitral valve surgery in the presence of extensive calcification of the mitral annulus is a technical challenge and increases perioperative risk. This study reviews our experience with decalcification of the mitral annulus in patients undergoing mitral valve reconstruction or replacement.

METHODS: From 1995 to 2003, 81 patients (mean age 64 +/- 13 years, 30 male, 51 female) with extensive calcification of the mitral annulus underwent mitral valve repair (n = 42) or replacement (biological n = 20, mechanical n = 19). The mean follow-up was 24 months. Patients presented with a mean EuroSCORE of 7. Concomitant surgical procedures were performed in 62 %. Patient outcomes were retrospectively assessed.

RESULTS: Perioperative survival was 97.5 % (n = 79) and hospital survival was 91.3 % (n = 74). Two-year survival was 88.9 %. Eight patients needed reexploration due to bleeding and five patients required prolonged mechanical ventilation. No perioperative stroke was observed. Freedom from reoperation was 90.2 % (n = 73). Early reoperation for recurrent incompetence was necessary in 3 patients and late reoperation in 5 patients.

CONCLUSIONS: Despite the elevated perioperative risk and the high risk of reoperation with this procedure, decalcification of the annulus and repair/replacement of the mitral valve could be performed with good clinical results.

Author(s): M Dietrich , M Doss , T Aybek , S Martens , M Scherer , G Wimmer-Greinecker, A Moritz

in: Thorac Cardiovasc Surg. 2006 Oct ;54 (7):464-467 17089313

Transapical aortic valve implantation: an animal feasibility study.

BACKGROUND: Percutaneous aortic valve implantation has recently been performed in nonsurgical patients with severe aortic stenosis. Retrograde valve delivery has been problematic because of the size of the delivery system and concomitant peripheral vascular disease. We investigated a minimally invasive approach through the left ventricular apex for antegrade placement of a device-deliverable valve.

METHODS: Transapical aortic valve implantation was performed using a 23-mm equine valve mounted on a stainless steel stent in 24 swine (weight range, 35 to 45 kg). A limited or full sternotomy approach was used to access the apex of the heart. The crimped valve was introduced through a sheath in the left ventricular apex. Fluoroscopy and echocardiography were used for guidance. Deployments were performed on the beating heart either with ventricular unloading using femoral extracorporeal circulation or rapid ventricular pacing.

RESULTS: All valves were successfully delivered at the selected target site with acceptable visualization of the noncalcified aortic annulus. Valve migration occurred during eight deployments (two distal and six retrograde) secondary to persistent cardiac output, unfavorable annular anatomy, and dislodgement by the delivery catheter. Exact positioning of the nonmigrated valves at the aortic annulus was examined by necropsy of all animals at the end of the procedures. Paravalvular leak was noted in 14 of 18 (77.8%) valves remaining in situ.

CONCLUSIONS: The transapical approach was used for the successful antegrade placement of a stented valve, obviating the technical problems associated with a large delivery system transiting the peripheral vascular system. Stent design contributing to paravalvular leak remains problematic.

Author(s): Dewey TM, Walther T, Doss M, Brown D, Ryan WH, Svensson L, Mihaljevic T, Hambrecht R, Schuler G, Wimmer-Greinecker G, Mohr FW, Mack MJ.

in: Ann Thorac Surg. 2006 Jul;82(1):110-6.

PMID: 16798200 [PubMed - indexed for MEDLINE]

Transapical approach for sutureless stent-fixed aortic valve implantation: experimental results.

OBJECTIVE: Percutaneous aortic valve implantation has been performed in patients with severe aortic stenosis judged as nonsurgical candidates. We evaluated a facilitated transapical antegrade approach for potential use in surgical high-risk patients.

METHODS: A pericardial xenograft fixed within a 23-mm stent (Cribier-Edwards aortic prosthesis, Edwards Inc., Irvine, CA, USA) was implanted using a transapical approach in fifteen 35-45 kg pigs. A limited or a full sternotomy was used to transapically introduce a crimped valve through a 24-F sheath. Deployments were performed on the beating heart either with ventricular unloading using femoro-femoral cardiopulmonary bypass (CPB) or rapid ventricular pacing (RVP), all under fluoroscopic and echocardiographic visualization.

RESULTS: All valves were successfully deployed at the target site with acceptable visualization of the noncalcified annulus. Valve migration occurred in six procedures (three distal and three retrograde) secondary to inadequate reduction of ventricular output, unfavorable annular anatomy, excessive crimping of the valve, and dislodgement by the delivery balloon. Exact positioning of the valve into the target area was confirmed by autopsy at the end of the procedures. Paravalvular leak was noted in five implants.

CONCLUSIONS: The transapical approach provides a safe, accurate, and effective route for facilitated antegrade delivery of a stent-fixed valve. Advanced stent design will lead to better stability of the implant and may minimize the risk of paravalvular leakage in future. Identifying the appropriate population for human feasibility trials remains a challenge.

Author(s): Walther T, Dewey T, Wimmer-Greinecker G, Doss M, Hambrecht R, Schuler G, Mohr FW, Mack M

in: Eur J Cardiothorac Surg. 2006 May;29(5):703-8. Epub 2006 Apr 5.

This paper was presented at the Annual Meeting of the European Society of Thoracic Surgeons No13, Barcelona , Spain (25. Sept. 2005)

PMID: 16600616 [PubMed - indexed for MEDLINE]

Left ventricular remodeling impacts the function of the Quattro stentless mitral valve bioprosthesis (a 4-year experience).

OBJECTIVE: The St Jude Quattro stentless mitral valve prosthesis (QMV) is sutured to the mitral annulus and the papillary muscle heads, thereby preserving the subvalvular apparatus. After mitral valve replacement, remodeling of the left ventricle is often observed, causing a dilated ventricle to shrink in diameter. It was our objective to assess these changes in left ventricular (LV) geometry and evaluate its effects on the function of the QMV.

METHODS: From September 1997 to October 2000, 24 patients received QMV at our institution. The patients were followed up at yearly intervals (mean 4.1 +/- 2.2 years). All pre- and postoperative echocardiograms were evaluated, with attention focused on the subvalvular apparatus, leaflet morphology, and occurrence of late mitral regurgitation. In addition, all clinical outcomes and valve-related complications were recorded.

RESULTS: Forty-one percent of patients (10/24) developed late mitral regurgitation (mild, n = 5; moderate, n = 5). The site of regurgitation was located at the 2 commissures in all cases. In 8 patients, changes in LV diameter had occurred. The point of leaflet coaptation had shifted away from the annulus in 4 patients. The overall mortality was 12.3%, and the postoperative stroke rate was 12.3%.

CONCLUSIONS: Midterm changes in LV geometry seem to affect the competence of the QMV. Predicting these changes and subsequently adapting the sizing procedure remain a challenging task. The high rate of late valve incompetence and poor clinical outcomes has prompted us to discontinue recruitment of patients for this trial.

Author(s): Mirko Doss, Tayfun Aybek, Jeffrey Paul Wood, Sven Martens, Gerhard Wimmer-Greinecker, Anton Moritz

in: Am Heart J. 2006 Apr ;151 (4):943.e1-4 16569568

Stentless bioprostheses improve postoperative coronary flow more than stented prostheses after valve replacement for aortic stenosis.

OBJECTIVE: In some randomized studies, stentless aortic valves have demonstrated hemodynamic advantages in comparison with stented prostheses. The effect of more physiologic flow dynamics on coronary artery flow has not been investigated yet. This study compares coronary perfusion after aortic valve replacement with stented or stentless porcine bioprostheses in a prospective randomized study.

METHODS: A total of 24 patients (73 +/- 6 years) referred for treatment of aortic stenosis were randomized to aortic valve replacement with stented (Medtronic Mosaic; (Medtronic Inc, Minneapolis, Minn) or stentless (Medtronic Freestyle; Medtronic Inc) prostheses. Coronary flow was measured by means of magnetic resonance imaging preoperatively, 5 days after the operation, and 6 months postoperatively, then with evaluation of coronary flow reserve. Echocardiography was performed to quantify transvalvular gradients and left ventricular mass regression.

RESULTS: Coronary flow increased in both groups significantly.

Author(s): Farhad Bakhtiary, Mirko Schiemann, Omer Dzemali, Thomas Wittlinger, Mirko Doss, Hans Ackermann, Anton Moritz, Peter Kleine

in: J Thorac Cardiovasc Surg. 2006 Apr ;131 (4):883-8 16580448

Impact of mechanical and biological aortic valve replacement on coronary perfusion: a prospective, randomized study.

BACKGROUND AND AIM OF THE STUDY: Coronary perfusion is impaired in patients with aortic stenosis (AS). Aortic valve replacement (AVR) leads to improvement, but not complete restoration, of coronary flow. Previous studies have shown that postoperative coronary flow rate and coronary reserve in mechanical valves is dependent on valve design and orientation. The study aim was to investigate acute changes in coronary perfusion in patients undergoing mechanical or biological valve replacement in a prospective, randomized clinical study.

METHODS: Forty patients undergoing AVR for AS underwent MRI scanning to measure coronary flow preoperatively and at five days after surgery. Patients scheduled for mechanical AVR (n = 20) were randomized to a tilting disc (Medtronic Hall) or bileaflet (Medtronic ADVANTAGE) prosthesis; the biological-valve group (n = 20) received a stented (Medtronic Mosaic) or stentless (Medtronic Freestyle) valve. Valve sizes were comparable in all groups. Patients also underwent echocardiography both preoperatively and postoperatively to measure transvalvular pressure gradients. The rate-pressure product (RPP) was calculated as a marker of myocardial oxygen demand and cardiac workload.

RESULTS: The mean preoperative coronary flow rate was 90 +/- 32 ml/min, and this increased after AVR in all patients. The rise in the mechanical-valve groups was comparable for the two tested valves, whereas in the biological-valve groups a significantly higher increase for stentless valves was present (p < 0.05). Mean pressure gradients for the Hall and ADVANTAGE valves were equal; for biological valves, the Mosaic demonstrated a higher mean gradient (19 +/- 6 mmHg) than the Freestyle (10 +/- 4 mmHg) (p < 0.05). The RPP was lower for ADVANTAGE (mechanical group) and for Freestyle valves (biological group).

CONCLUSION: Coronary artery flow was increased following AVR in all valve groups. The rise was significantly more distinct for Medtronic Freestyle stentless valves compared to the three other valve substitutes. As the stentless design also demonstrated superior hemodynamics and a lower myocardial oxygen demand with lower pressure gradients and lower RPP, this may have a positive impact on the clinical long-term outcome of this valve.

Author(s): Farhad Bakhtiary MD, Nasreddin Abolmaali MD, Omer Dzemali MD, Thomas Wittlinger MD, Mirko Doss MD, Anton Moritz MD, Peter Kleine MD

in: J Heart Valve Dis. 2006 Jan;15(1):5-11; discussion 11

 

PMID: 16480006 [PubMed - indexed for MEDLINE]

Do pulmonary autografts provide better outcomes than mechanical valves? A prospective randomized trial.

BACKGROUND: The objective of this study was to compare the performance of pulmonary autografts with mechanical aortic valves, in the treatment of aortic valve stenosis.

METHODS: Forty patients with aortic valve stenoses, and below the age of 55 years, were randomly assigned to receive either pulmonary autografts (n = 20) or mechanical valve (Edwards MIRA; Edwards Lifesciences, Irvine, CA) prostheses (n = 20). Clinical outcomes, left ventricular mass regression, effective orifice area, ejection fraction, and mean gradients were evaluated at discharge, 6 months, and one year after surgery. Follow-up was complete for all patients.

RESULTS: Hemodynamic performance was significantly better in the Ross group (mean gradient 2.6 mm Hg vs 10.9 mm Hg, p = 0.0005). Overall, a significant decrease in left ventricular mass was found one year postoperatively. However, there was no significant difference in the rate and extent of regression between the groups. There was one stroke in the Ross group and one major bleeding complication in the mechanical valve group. Both patients recovered fully.

CONCLUSIONS: In our randomized cohort of young patients with aortic valve stenoses, the Ross procedure was superior to the mechanical prostheses with regard to hemodynamic performance. However, this did not result in an accelerated left ventricular mass regression. Clinical advantages like reduced valve-related complications and lesser myocardial strain will have to be proven in the long term.

Author(s): Mirko Doss, MD , Jeffrey P. Wood, MD, Sven Martens, MD, Gerhard Wimmer-Greinecker, MD, Anton Moritz, MD

in: Ann Thorac Surg. 2005 Dec;80(6):2194-8

PMID: 16305870 [PubMed - indexed for MEDLINE]

Pericardial patch augmentation for reconstruction of incompetent bicuspid aortic valves.

PURPOSE: Reoperation rates after repair of bicuspid aortic valves are higher than for mitral valve reconstruction. Secondary changes and small coaptation surface render repair unreliable. Satisfactory results have been reported for patch augmentation for tricuspid aortic valves. We have applied this technique for the repair of bicuspid aortic valves.

DESCRIPTION: Our technique retains the bicuspid morphology of the incompetent aortic valve. A strip of glutaraldehyde-fixed pericardium is sutured to the free edge of the fused leaflet. A large coaptation surface is created, and competence of the bicuspid valve is achieved.

EVALUATION: Sixteen patients underwent reconstruction of their bicuspid aortic valves by pericardial patch augmentation. There were no intraoperative or postoperative deaths. The degree of aortic regurgitation was none to trivial for all patients at a mean follow-up of 3.1 +/- 3.4 months. Planimetric effective orifice areas ranged above 2 cm2. Mean aortic gradients were 8.2 +/- 4.8 mm Hg, and the mean height of coaptation surface was 14.7 +/- 2.1 mm.

CONCLUSIONS: The pericardial patch augmentation technique increases coaptation surface, and thus provides reliable early competence of reconstructed bicuspid aortic valves.

Author(s): Doss M, Moidl R, Wood JP, Miskovic A, Martens S, Moritz A

in: The Annals of Thoracic Surgery, 2005 Jul;80(1):304-7.

PMID: 15975387 [PubMed - indexed for MEDLINE]

Echocardiographic assessment in minimally invasive mitral valve surgery.

BACKGROUND: Due to limited exposure, removal of intracavitary air and visual assessment of cardiac function during minimally invasive procedures are not always possible. We analysed the utility of intraoperative transesophageal echocardiography (TEE) and postoperative transthoracic echocardiographic (TTE) in minimally invasive mitral valve (MV) procedures.

MATERIAL/METHODS: We evaluated data from 163 consecutive patients undergoing isolated minimally invasive MV replacement (n=40) or repair (n=123) via small right anterolateral thoracotomy (121 complex mitral procedures). Cardioplegic arrest was achieved using either endoaortic (n=23) or transthoracic aortic clamp (n=140). In addition to preoperative TTE, TEE was used intraoperatively before and after cardiopulmonary bypass (CPB). Postoperative TTE was performed to monitor valve function at 3 and 12 months, and at 5-year follow-up.

RESULTS: Pre-CPB TEE was useful to assess valve dysfunction and assist in placement of the arterial and venous cannulas. During CPB, placement and positioning of the endoclamp were guided effectively in all but 4 patients, in whom recurrent balloon migration necessitated secondary transthoracic aortic clamping. TEE detected one acute retrograde aortic dissection and one circumflex artery occlusion. After 18.7+/-10.6 months follow-up, all patients except three improved symptomatically and had consistently good valve function.

CONCLUSIONS: Intraoperative TEE is essential for minimally invasive MV surgery, because it allows immediate control of valve function before and after surgery. It is useful to detect unexpected complications requiring immediate remedy. Postoperative echocardiographic results show that minimally invasive MV surgery is a good alternative to conventional surgery even in complex MV repairs.

Author(s): Aybek T, Doss M, Abdel-Rahman U, Simon A, Miskovic A, Risteski PS, Dogan S, Moritz A.

in: Med Sci Monit. 2005 Apr;11(4):MT27-32. Epub 2005 Mar 24

PMID: 15795704 [PubMed - indexed for MEDLINE]

Aortic leaflet replacement with the new 3F stentless aortic bioprosthesis.

PURPOSE: Clinical trials with the new 3F stentless aortic bioprosthesis began October 2001, and as one of the first centers to implant this prosthesis in humans, we would like to present our experiences with this new device.

DESCRIPTION: The 3F aortic bioprosthesis is a stentless biological heart valve fabricated from three equal leaflets of equine pericardium, assembled in a tubular shape, and implanted in the native aortic root to replace the patient’s diseased aortic leaflets. Between January 2002 and August 2002, 24 3F aortic bioprostheses were implanted at our institution. Effective orifice area, mean gradients, and ejection fraction were evaluated by echocardiography at discharge and at 12-month follow-ups after surgery.

EVALUATION: At 12-month follow-ups, the 3F bioprosthesis showed a good hemodynamic performance with a significant drop of mean gradients to 10.3 mm Hg, a mean effective orifice area of 1.7 cm2, and a mean ejection fraction of 61.5%.

CONCLUSIONS: The clinical performance of the new 3F aortic bioprosthesis is comparable with regular stentless aortic valves. However its unique design facilitates implantation.

Author(s): Doss M, Martens S, Wood JP, Miskovic A, Christodoulou T, Wimmer-Greinecker G,
in: The Annals of Thoracic Surgery, 2005 Feb;79(2):682-5; discussion 685

PMID: 15680860 [PubMed - indexed for MEDLINE]

Valve opening and closing dynamics after different aortic valve-sparing operations.

BACKGROUND AND AIM OF THE STUDY: Aortic valve resuspension for ascending aortic aneurysm repair is associated with removal of the sinus of Valsalva. This may cause changes in leaflet motion and thus impact on long-term durability. The opening and closing characteristics of the aortic valve leaflets after reimplantation were studied using a published technique and a modification to create a ‘neosinus’, and the results compared to those of an age-matched control group.

METHODS: Between September 1995 and March 2002, 25 patients underwent normal aortic root reconstruction (group A), while in a further 21 patients the modified neosinus technique was used (group B). In both groups, the native valve was preserved and suspended inside a tubular prosthesis, with reimplantation of the coronary arteries. Transthoracic and transesophageal studies of aortic valve dynamics were performed intraoperatively, before hospital discharge, and at one year after surgery in all patients; the data were compared with those from a separate group of 25 matched control individuals (group C).

RESULTS: The valve opening velocity was 61.3+/-20.1, 46.3+/-8 and 29.2+/-9.8 cm/s in groups A, B and C, respectively (group A versus B, p = 0.003; A versus C, p <0.0001; B versus C, p <0.0001). Closing velocity was increased to 57.5+/-23 and 43.8+/-7 cm/s in groups A and B, compared to 23.6+/-7 cm/s in group C (A versus B, p = 0.012; A versus C, p <0.0001; B versus C, p = 0.0002). In seven group A patients, the leaflets touched the prosthetic wall during systole. Slow systolic closing displacement (SCD) amounted to 7.3+/-6 % of maximal opening in group A and 12.6+/-5 % in group B (p = 0.05), compared to 21.1+/-8.3% in group C (group A versus group C, p <0.0001; B versus C, p = 0.002).

CONCLUSION: Reimplantation of the natural aortic valve in a prosthetic graft causes abnormally high opening and closing speeds, with possibly increased stress. The study results showed lower valve opening and closure dynamics after the creation of a sinus bulge compared to the conventional reimplantation technique. However, mid-term clinical observations showed favorable valve competence for both types of repair. Further long-term follow up is necessary to prove whether more physiological leaflet dynamics lead to improved durability.

Author(s): Aybek T, Sotiriou M, Wohleke T, Miskovic A, Simon A, Doss M, Dogan S, Wimmer-Greinecker G, Moritz A.

in: J Heart Valve Dis. 2005 Jan;14(1):114-20.

PMID: 15700445 [PubMed - indexed for MEDLINE]

Effects of geometric left ventricular remodelling on the function of stentless quadrileaflet mitral valve bioprostheses. A four year experience.

OBJECTIVES: The stentless quadrileaflet mitral valve prosthesis (QMV) is sutured to the mitral annulus and the papillary muscle heads, thereby preserving the subvalvular apparatus. After mitral valve replacement, remodeling of the left ventricle is often observed, causing a dilated ventricle to shrink in diameter. Thus, the distance between annulus and papillary heads, which in the QMV is fixed at the time of surgery by the papillary flaps, also changes with time and might cause late mitral valve incompetence.

METHODS: From September 1997 to October 2000, 24 patients received QMV at our institution. The patients were followed up at yearly intervals (mean 4.04 years /range 2-5). All pre- and postoperative echocardiograms were evaluated, with attention focused on the subvalvular apparatus, leaflet morphology and occurrence of late mitral regurgitation.
RESULTS: 41% patients (10/24) developed late mitral regurgitation ( mild n=5, moderate n=5).The site of regurgitation was located at the two commisures in all cases. In eight patients changes in left ventricular diameter had occurred. The point of leaflet coaptation had shifted away from the annulus in four patients.

CONCLUSIONS: Midterm changes in left ventricular geometry seem to affect the competence of the QMV. As late regurgitation always occurred at the commissures, we have to consider that rotational remodeling of the left ventricle also took place. Predicting these changes and subsequently adapting the sizing procedure remains a challenging task.

Author(s): Doss M, Aybek T, Wood JP, Martens S, Wimmer-Greinecker G, Moritz A.
in: 2003,
Society for Heart Valve Disease 2nd Biennial Meeting, Paris / France

Performance of stentless versus stented aortic valve bioprostheses in the elderly patient: a prospective randomized trial.

OBJECTIVES: Although stentless aortic bioprostheses are believed to offer improved outcomes, benefits remain unsubstantiated. The aim of our study was to compare stentless with stented bioprostheses, with regard to postoperative changes in left ventricular mass and hemodynamic performance, in the elderly patient.

METHODS: Forty patients with aortic stenoses, over the age of 75 years, were randomized to receive either the stented Perimount (n=20) or the stentless Prima Plus (n=20) bioprosthesis. Left ventricular mass regression, effective orifice area, ejection fraction and mean gradients were evaluated at discharge, 6 months and 1 year after surgery.

RESULTS: Overall a significant decrease in left ventricular mass was found 1 year postoperatively. However, there was no significant difference in the rate of left ventricular mass regression between the groups. Furthermore, 1 year postoperatively, the hemodynamic performance of the valves and the change in the ejection fraction did not differ between the groups.

CONCLUSIONS: Our study shows that in a randomized cohort of elderly patients with aortic stenosis, we were not able to detect significant differences, with regard to hemodynamic performance and regression of left ventricular mass, between the stentless and stented valve groups. To our surprise, previously reported findings of non-randomized trials that showed faster and more complete regression of left ventricular mass and hemodynamic benefits of stentless valves were not reproducible.

Author(s): Doss M, Martens S, Wood JP, Aybek T, Kleine P, Wimmer Greinecker G, Moritz A.
in: Eur J Cardiothorac Surg. 2003 Mar;23(3):299-304.

PMID: 12614797 [PubMed - indexed for MEDLINE]

Minimally invasive versus conventional aortic valve replacement: a prospective randomized trail

BACKGROUND AND AIM OF THE STUDY: A prospective randomized study was performed to compare conventional with minimally invasive aortic valve replacement (AVR).

METHODS: Forty consecutive patients scheduled for elective aortic valve surgery were prospectively randomized either to the conventional group (group A, complete median sternotomy) or minimally invasive group (group B, partial upper sternotomy). Intraoperative and postoperative clinical data, and markers of myocardial and cerebral protection were determined. Neuropsychological tests were carried out to quantify psychological disorders.

RESULTS: Operative time and cardiopulmonary bypass time were slightly longer in group B, but not significantly so. No significant inter-group differences were found for postoperative pain scores and respiratory function. Chest tube drainage was significantly less in group B (495 +/- 165 versus 240 +/- 69 ml, p = 0.008). Creatine kinase (CK), CK-MB and troponin T levels were similar in both groups. Neither S-100B protein nor neuron-specific enolase levels differed significantly between groups at all sampling times. There were no strokes in the entire cohort. None of the neuropsychological tests yielded significant inter-group differences between conventional and minimally invasive surgery. C

CONCLUSION: The safety and reliability of AVR via a partial upper sternotomy is reported. Minimally invasive AVR can be performed with only slightly longer operative times, good cosmetic results and significantly less blood loss. A limited surgical access affected neither the patients’ neurological outcome nor the efficacy of myocardial protection.

Author(s): Dogan S, Dzemali O, Wimmer-Greinecker G, Derra P, Doss M, Khan MF, Aybek T, Kleine P, Moritz A.

in: J Heart Valve Dis. 2003 Jan;12(1):76-80.

Leaflet escape in a Tekna and an original Duromedics bileaflet valve.

We report a case of leaflet escape in an Edwards-TEKNA bileaflet valve, in the mitral position. The examination findings of the explanted valve are compared with a similar case of leaflet escape in an original Edward-Duromedics prosthesis. Based on our findings alone, it is not certain whether the TEKNA valve continues to have a higher risk for fracture.

Of about 20,000 original Edwards – Duromedics bileaflet valves ( Baxter Healthcare Corp , Santa Ana , CA ) ( models 3160 and 9120 ) implanted from 1982 to 1988 , 12 cases of leaflet embolization from the mitral position were reported [ 1 ] . The prosthesis was subsequently withdrawn from the market and reintroduced after modifications as the revised Edwards – Duromedics or TEKNA valve ( models 3160R , 3200 and 9120R , and 9200 ) in June 1990. In recent years , we had to carry out two emergency reoperations due to leaflet embolization of Duromedics prostheses. We report a case of a fractured TEKNA prosthesis as well as the case of a fractured original Duromedics prosthesis.

Case reports

Case 1
A 37 – year-old man was admitted to our Department of Cardiology , with acute onset of severe pulmonary edema and low cardiac output. He had undergone mitral valve replacement with a TEKNA prosthesis ( model 9120R , size 27 mm ) 3 years earlier. Severe mitral regurgitation was diagnosed. The intraoperative findings confirmed an absent posterior mitral valve leaflet. After complete excision of the valve , the left ventricle was palpated in an attempt to retrieve embolized fragments of the leaflet. However , this was unsuccessful. The old valve was replaced by a 29 – mm Medtronic Hall prosthesis ( Medtronic Inc , Minneapolis , MN ) . A search for the remaining embolized leaflet particles was undertaken. By computed tomography , one particle was localized at the aortic bifurcation and another in the left common iliac artery. Both were removed via a transperitoneal approach. They were found to be nearly identical in size , confirming that the leaflet had been broken in half ( Fig 1A , B ) . All parts of the explanted valve were returned to the manufacturing company. The patient made a good recovery.

(Fig 1. Central fracture of a leaflet ( case 1 ) , showing both fragments.)

Case 2
A 64 – year-old man who had undergone mitral valve replacement with a Duromedics prosthesis ( model 9120 , size 31 mm ) in 1986 was admitted to our Department of Cardiology with signs of fulminant pulmonary edema. Cardiac catheterization demonstrated severe mitral regurgitation and a critical stenosis of the right coronary artery. Intraoperatively , the mitral valve prosthesis showed a missing posterior leaflet. The valve was replaced by a 25 – mm Medtronic Hall prosthesis and the patient received a saphenous vein graft to the right coronary artery. Similar to the first case , no periphery pulse deficit gave us an indication to the location of embolization. A foreign body was located in the left common iliac artery by computed tomography and clearly identified in the proximal external iliac artery by B – mode ultrasonic examination. The leaflet was recovered via a retroperitoneal approach. The fracture had occured at one of the pivot balls ( Fig 2 ) . The patient made an uneventful recovery postoperatively. The explanted valve fragments were again sent to the manufacturing firm for inspection.

(Fig 2. Recovered leaflet from second patient ; fracture in the region of the pivoting system.)

Examination of the explanted valve fragments

Case 1
A region of pyrolytic carbon loss , approximately 2 mm in length and 80 ( mu ) m in depth , was observed on the seating lip , which coincided with the location of the central fracture of the leaflet. This pyrolytic carbon loss appeared to be primarily the result of impact as opposed to cavitation or erosion , which are usually related to material quality and flow.

Case 2
Contrary to case 1 , the second case showed a fracture at the leaflet’s pivoting system. Substantial damage in the form of severe pitting on the corresponding pivot slot edge was present.

Comment
Cavitation has been recognized as the reason for the series of valve failures in the Edwards – Duromedics prosthesis. Typical forms of damage attributed to cavitation are pitting and microcracking , which can later give rise to complete fractures , eg , of leaflets. The original Duromedics valve was shown to be more susceptible to cavitation than other comparable bileaflet valves. This was attributed to high velocities on valve closure , especially in surfaces of the inflow side. Cavitation also seems to be promoted by the seating lip , found in Duromedics valves , which halts leaflet movement and can cause high – velocity pressure jets [ 2 and 3 ] . The experience gained from the original Duromedics valve led to several modifications , especially aimed at reducing the valve – closing velocity and the forces of cavitation. The radius of the seating lip was changed , a shock absorber was integrated into the sewing ring , and minor changes of the pivoting joints and the porosity of the material were initiated [ 4 ] . In vitro investigations showed higher cavitation thresholds for the TEKNA valve , comparable with the results for other bileaflet valves [ 5 ] . These findings , however , were not confirmed by all authors. The manufacturing firm reported three cases of leaflet escape for the revised model in 1996 [ 6 ] ; the explanted valves did not show changes typical for cavitation. As a possible reason for valve failure , we must also consider small irregularities in the structure of the material used. Pyrolytic carbon is a very hard but also very brittle substance. Therefore , its surface can be damaged by improper handling , eg , contact with a metallic tool. The currently available clinical data on the TEKNA valve do not show a high risk for fracture. Valve defects , typical for cavitation , have so far not been reported. These early results will have to be confirmed by the clinical course of the coming years.

REFERENCES:

1. Radlick PH. Suspension of marketing Edwards Duromedics bileaflet valve models 3160 and 9120, all sizes. Baxter, Important product information, Santa Ana, CA, 1988:1-2..

2. G. Richard, A. Beavan and P. Strzepa, Cavitation threshold ranking and erosion characteristics of bileaflet heart valve prostheses. J Heart Valve Dis 3 Suppl I (1994), pp. 94-103.

3. G.X. Guo, T.H. Chiang, R.C. Quijano and N.H.C. Hwang, The closing velocity of mechanical heart valve leaflets. Med Eng Phys 16 (1994), pp. 458-464.

4. A. Moritz, W. Klepvtko, S. Rodler et al., Six-year follow-up after heart valve replacement with the Edwards Duromedics bileaflet prosthesis. Eur J Cardiothorac Surg 7 (1993), pp. 84-90.

5. C. Kingsbury, R. Kafesjian, G. Guo et al., Cavitation threshold with respect to dP/dt: evaluation in 29 mm bileaflet, pyrolitic carbon heart valves. Int J Artif Organs 16 (1993), pp. 515-520.

6. Edwards TEKNA bileaflet valve clinical report, June 1996. Baxter Healthcare Corporation, Santa Ana, CA, 1996.. (REcor) Address reprint requests to Dr Hemmer, Sana Herzchirurgische Klinik, Herdweg 2, D-70174 Stuttgart, Germany

Author(s): Hemmer W, Doss M, Hannekum A, Kapfer X.

in: Annals of Thoracic Surgery 2000 Mar;69(3):942-4.

Links:

PMID: 10750795 [PubMed - indexed for MEDLINE]

Follow

Get every new post delivered to your Inbox.